End-of-day quote
Korea S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
2,060
KRW
|
-0.24%
|
|
-1.20%
|
-14.52%
|
2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
| 2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
|
|
2024-05-27
|
2024-05-28
|
2024-05-29
|
2024-05-30
|
2024-05-31
|
Last |
2085 ₩
|
2080 ₩
|
2060 ₩
|
2065 ₩
|
2060 ₩
|
Volume |
252 621 |
142 914 |
237 279 |
134 457 |
291 319 |
Change |
-.--%
|
-0.24%
|
-0.96%
|
+0.24%
|
-0.24%
|
Opening |
2,090.00 |
2,080.00 |
2,085.00 |
2,070.00 |
2,060.00 |
High |
2,095.00 |
2,090.00 |
2,085.00 |
2,070.00 |
2,075.00 |
Low |
2,065.00 |
2,070.00 |
2,060.00 |
2,055.00 |
2,045.00 |
Avg. Volume 20 sessions
213 145
Avg. Volume 20 sessions KRW
439 078 700.00
Avg. Volume 20 sessions USD
317 014.82
Record volume 1
102 949 900
Record volume 2
81 278 730
Record volume 3
80 941 210
Capital turnover ratio
0.00
Capitalization (KRW)
286 554 886 427
Capitalization (USD)
206 892 628
Net sales (KRW)
93 906 675 100
Net sales (USD)
67 800 619
Sales / Employee (KRW)
700 796 083
Sales / Employee (USD)
505 975
Free-Float capitalization (KRW)
212 498 051 194
Free-Float capitalization (USD)
153 423 593
Average Daily Capital Traded
0.15%
Moving average 5 days
2 070.00
Moving average 20 days
2 102.00
Moving average 50 days
2 145.50
Moving average 100 days
2 202.00
Price spread / (MMA5) +0.49% Price spread / (MMA20) +2.04% Price spread / (MMA50) +4.15% Price spread / (MMA100) +6.89%
More charts
|